ArticlePloS one2026
Clinical impact of hospital distance and center transfers on adherence and outcomes in familial adenomatous polyposis: A multicenter retrospective study in a defined region of Japan.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to evaluate how hospital distance and changes in surveillance hospitals influence adherence to surveillance, the cumulative risk of familial adenomatous polyposis-related tumors, and survival outcomes in patients with familial adenomatous polyposis. We conducted a multicenter retrospective study in a specific region of Japan and analyzed 79 patients with familial adenomatous polyposis who underwent total colectomy or proctocolectomy between 1987 and 2025 across 9 accredited hospitals. We examined the associations between straight-line distance to the hospital, changes in surveillance centers, and surveillance adherence, as well as the cumulative risk of familial adenomatous polyposis-related tumors and survival outcomes. The 10-year surveillance adherence rate was 86.5%. During follow-up, 31.6% of patients changed hospitals. Hospital distance did not differ significantly between those who maintained or dropped out of surveillance. However, patients residing ≥40 km from their hospital were significantly more likely to switch hospitals (61.5% vs. 13.2%, p < 0.001). Importantly, changes in surveillance hospitals showed no significant association with the cumulative risk of familial adenomatous polyposis-related tumors or survival outcomes. Surveillance dropout occurred in 7.6% of patients. No specific clinical predictors of surveillance dropout were identified; the most common reason for surveillance dropout was patients' self-assessed low risk following negative screening results. This multicenter study found that hospital distance or changes in surveillance hospitals did not significantly affect adherence to surveillance or clinical outcomes in patients with familial adenomatous polyposis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.